Human Donor Blood for Bioassay Development
Closed Solicitation Posted
- Solicitation number
- 75F40124Q00461
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Silver Spring, Maryland 20903, United States
- Points of contact
-
- Patricia Natividad patricia.natividad@fda.hhs.gov (301) 796-8919
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Food and Drug Administration (FDA) is seeking to procure human donor blood for the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells. This contract will be awarded as a firm-fixed price on a full and open basis under NAICS code 621991 - Blood and Organ Banks. The solicitation is being issued as a Request for Quote (RFQ), with quotes due by August 13, 2024 at 10:00 AM Eastern Time. The Government reserves the right to award without discussions if the initial offer is determined to provide the best value. Key requirements include pricing, technical acceptability, and electronic invoicing and payment through the Invoice Processing Platform.
This contract has no set-aside designation. The place of performance is Silver Spring, MD 20903. The period of performance is from September 30, 2024 to February 28, 2024, with deliveries required 2 times per month of 2-4 leukopaks containing approximately 2.5 billion cells. No potential incumbents or current contractors are named, and no award value or budget range is provided in the solicitation notice.
Notice text
Solicitation Number:75F40124Q00412
This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in FAR 12.6 and FAR 13 as supplemented and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05, effective 05/22/2024.
THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE
SOLICITATION WILL NOT BE ISSUED.
The solicitation number for this acquisition is 75F40124Q00412 and is being issued as a Request for Quote (RFQ). The NAICS Code for this solicitation is 621991. This will be awarded as Firm-Fixed Price as competed as Full and Open. Prospective Offerors are responsible for downloading the solicitation and any amendments from SAM.GOV. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing the Best Value and discussions are not necessary.
The U.S. Food and Drug Administration (FDA) requires a Human Donor Blood for BioAssay Development Delivery.
A. OBJECTIVES/PURPOSE
For the development of bioassays using peripheral blood mononuclear cells (PBMC) and/or isolated immune cells, we require a reliable and steady source of blood products from human donors.
See attached RFQ CB Synopsis Solicitation .
Attachments
| File | Type | Posted |
|---|---|---|
| RFQ CB SYNOPSIS SOL CDER-2024-123840 08032024.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity